Beta-lactam antibiotic and macrolide antibiotic combination

This page covers all Beta-lactam antibiotic and macrolide antibiotic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial cell wall (ceftriaxone) and bacterial 50S ribosome (azithromycin), Bacterial cell wall (amoxicillin); bacterial 50S ribosome (clarithromycin).

Targets

Bacterial cell wall (ceftriaxone) and bacterial 50S ribosome (azithromycin) · Bacterial cell wall (amoxicillin); bacterial 50S ribosome (clarithromycin)

Marketed (2)

• ceftriaxone and azithromycin · Sheba Medical Center · Infectious Disease
  This combination uses a third-generation cephalosporin to inhibit bacterial cell wall synthesis and a macrolide antibiotic to inhibit bacterial protein synthesis, providing broad-spectrum coverage against respiratory pathogens.
• Amoxicillin, Clarithromycin · Mackay Memorial Hospital · Infectious Disease
  Amoxicillin and clarithromycin are antibiotics that work together to inhibit bacterial protein synthesis and cell wall formation, commonly used in combination therapy for H. pylori eradication.